232 related articles for article (PubMed ID: 27841295)
1. Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9.
Chou YY; Krupp A; Kaynor C; Gaudin R; Ma M; Cahir-McFarland E; Kirchhausen T
Sci Rep; 2016 Nov; 6():36921. PubMed ID: 27841295
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.
Wollebo HS; Bellizzi A; Kaminski R; Hu W; White MK; Khalili K
PLoS One; 2015; 10(9):e0136046. PubMed ID: 26360417
[TBL] [Abstract][Full Text] [Related]
3. JC Polyomavirus Infection Reveals Delayed Progression of the Infectious Cycle in Normal Human Astrocytes.
Wilczek MP; DuShane JK; Armstrong FJ; Maginnis MS
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826993
[TBL] [Abstract][Full Text] [Related]
4. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
5. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
[TBL] [Abstract][Full Text] [Related]
6. Establishment of COS-JC cells persistently producing archetype JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Microbiol Immunol; 2018 Aug; 62(8):524-530. PubMed ID: 29932215
[TBL] [Abstract][Full Text] [Related]
7. Adipocyte Plasma Membrane Protein (APMAP) promotes JC Virus (JCPyV) infection in human glial cells.
Haley SA; O'Hara BA; Atwood WJ
Virology; 2020 Sep; 548():17-24. PubMed ID: 32838939
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
Nukuzuma S; Nakamichi K; Kameoka M; Sugiura S; Nukuzuma C; Tasaki T; Takegami T
Microbiol Immunol; 2016 Apr; 60(4):253-60. PubMed ID: 26935240
[TBL] [Abstract][Full Text] [Related]
9. IFNα and β Mediated JCPyV Suppression through C/EBPβ-LIP Isoform.
May D; Bellizzi A; Kassa W; Cipriaso JM; Caocci M; Wollebo HS
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696366
[TBL] [Abstract][Full Text] [Related]
10. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
11. ERK Is a Critical Regulator of JC Polyomavirus Infection.
DuShane JK; Wilczek MP; Mayberry CL; Maginnis MS
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321332
[TBL] [Abstract][Full Text] [Related]
12. Phosphoinositide 3'-Kinase γ Facilitates Polyomavirus Infection.
Clark P; Gee GV; Albright BS; Assetta B; Han Y; Atwood WJ; DiMaio D
Viruses; 2020 Oct; 12(10):. PubMed ID: 33092168
[TBL] [Abstract][Full Text] [Related]
13. Characterization of JC Polyomavirus Derived from COS-IMRb Cells.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Jpn J Infect Dis; 2021 Jan; 74(1):48-53. PubMed ID: 32741932
[TBL] [Abstract][Full Text] [Related]
14. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
15. CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Takegami T
Microbiol Immunol; 2017 Jun; 61(6):232-238. PubMed ID: 28463406
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
[TBL] [Abstract][Full Text] [Related]
17. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
18. A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient.
Bialasiewicz S; Hart G; Oliver K; Agnihotri SP; Koralnik IJ; Viscidi R; Nissen MD; Sloots TP; Burke MT; Isbel NM; Burke J
Transplantation; 2017 Jun; 101(6):1461-1467. PubMed ID: 27367472
[TBL] [Abstract][Full Text] [Related]
19. Archetype JC Polyomavirus (JCPyV) Prevails in a Rare Case of JCPyV Nephropathy and in Stable Renal Transplant Recipients With JCPyV Viruria.
Seppälä HM; Helanterä IT; Laine PKS; Lautenschlager IT; Paulín LG; Jahnukainen TJ; Auvinen POV; Auvinen E
J Infect Dis; 2017 Nov; 216(8):981-989. PubMed ID: 28968776
[TBL] [Abstract][Full Text] [Related]
20. Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy.
Seppälä H; Virtanen E; Saarela M; Laine P; Paulín L; Mannonen L; Auvinen P; Auvinen E
J Infect Dis; 2017 Mar; 215(6):889-895. PubMed ID: 28453853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]